Navigation Links
Novel polymer could improve protein-based drugs
Date:8/19/2009

DURHAM, N.C. A new method for attaching a large protective polymer molecule to a protein appears to improve protein drugs significantly.

Bioengineers at Duke University developed the new approach and demonstrated in an animal model that the newly created protein-polymer combinations, known as conjugates, remained in circulation significantly longer than an unprotected protein.

The scientists say they are encouraged that their findings represent a new strategy to improve the efficacy of protein drugs.

Protein-based drugs are an increasingly important new class of drugs, said Ashutosh Chilkoti, Theo Pilkington Professor of Biomedical Engineering at Duke's Pratt School of Engineering. He cited such examples as insulin for the treatment of diabetes and more exotic "magic bullet" antibodies like herceptin that are used to treat certain cancers.

Unmodified proteins that are injected into the blood are quickly recognized by the body and broken down or cleared by the body's defense system, which limits their effectiveness as drugs. To get around this problem, drug makers have been attaching another molecule, a polymer known as polyethyleneglycol (PEG), to the protein in order to protect it. But this approach has its own drawbacks.

"The current method of combining the two molecules often only works with 10 to 20 percent efficiency, so that a lot of the very expensive starting materials are wasted," said Chilkoti, who had the results of his team's experiments published this week online in the Proceedings of the National Academy of Sciences. "Additionally, the two large molecules are attached by a small chemical link and often these linkages can occur at many different sites on the protein, so the final product is poorly defined."

Chilkoti took a different approach. Instead of combining two large molecules, he grew the polymer out from the protein itself, increasing the efficiency of the protein by more than 70 percent and greatly extending the amount of time it remained active in a living model.

"We also addressed the problem of getting a pure and well-defined product by growing the polymer from a single, unique site on the protein," he said. "Another twist to our work is that instead of using PEG, we used a somewhat different polymer that turns out to be as good and perhaps even better than PEG in extending circulation of the protein in the body."

There are many protein-polymer based medications in use today, such as human growth hormones, drugs to stimulate blood cell formation in cancer patients and anti-viral agents. Chilkoti will be reviewing existing protein-polymer drugs to determine if the new technique can improve their effectiveness.

In their experiments, the researchers used myoglobin, a protein responsible for creating the red pigments that give meat its color. Instead of creating a chemical bond between myoglobin and the polymer, the Duke researchers chose a specific spot on the protein, known as the N-terminus, and then grew the polymer from that specific location. Every protein has an N-terminus, so this method should be broadly useful, Chilkoti said.

After demonstrating they could create a stable compound using the new method, the researchers tested how well it worked by comparing its actions to the conventional compound in mice.

"The conventional compound myoglobin had a half-life of three minutes and was totally eliminated by two hours," Chilkoti explained. "By contrast, the new compound had a half-life 40 times greater and remained in circulation for 18 hours. The longer a protein remains in the system and is active, the more it helps the patient."

"The dramatic improvement in how the new compound acted encourages us that this new approach will have broad applications in improving the efficacy of many protein drugs," Chilkoti said.

Another benefit of this approach, according to Chilkoti, is that the polymer should naturally degrade in the body over time and be easily excreted. "Because the compound is biodegradable, we should in principle be able to make even larger protein-polymer combinations with potentially even better pharmacologic properties," he said.

The researchers plan to apply their invention to other protein-based therapies, such as for cancer and diabetes, to determine if they can improve effectiveness of the protein drug while reducing its undesirable toxic effects.


'/>"/>

Contact: Richard Merritt
Richard.merritt@duke.edu
919-660-8414
Duke University
Source:Eurekalert

Related biology news :

1. MGH researchers describe new way to identify, evolve novel enzymes
2. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
3. Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
4. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
5. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
6. 454 Sequencing: Science paper describes a novel, highly efficient method of sequencing ancient DNA
7. Scientists discover novel way to remove iron from ferritin
8. Identification of a novel class of (not-so) small RNAs
9. A novel way found to prevent protein plaques implicated in Alzheimers
10. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
11. Feinstein researchers develop new genetic method and identify novel genes for schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... June 22, 2016 Research and Markets has ... report to their offering. ... 2014 from $29.3 billion in 2013. The market is expected to ... from 2015 to 2020, increasing from $50.6 billion in 2015 to ... forecasts during the forecast period (2015 to 2020) are discussed. As ...
Breaking Biology Technology: